JP2000517292A5 - - Google Patents

Download PDF

Info

Publication number
JP2000517292A5
JP2000517292A5 JP1997537492A JP53749297A JP2000517292A5 JP 2000517292 A5 JP2000517292 A5 JP 2000517292A5 JP 1997537492 A JP1997537492 A JP 1997537492A JP 53749297 A JP53749297 A JP 53749297A JP 2000517292 A5 JP2000517292 A5 JP 2000517292A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997537492A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000517292A (ja
JP4155598B2 (ja
Filing date
Publication date
Priority claimed from GBGB9619082.2A external-priority patent/GB9619082D0/en
Priority claimed from GBGB9707394.4A external-priority patent/GB9707394D0/en
Application filed filed Critical
Priority claimed from PCT/NZ1997/000117 external-priority patent/WO1998011101A2/en
Publication of JP2000517292A publication Critical patent/JP2000517292A/ja
Publication of JP2000517292A5 publication Critical patent/JP2000517292A5/ja
Application granted granted Critical
Publication of JP4155598B2 publication Critical patent/JP4155598B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53749297A 1996-09-12 1997-09-12 抗癌剤としての縮合n−アシルインドール Expired - Fee Related JP4155598B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9619082.2 1996-09-12
GBGB9619082.2A GB9619082D0 (en) 1996-09-12 1996-09-12 Further cyclopropylindoles and their seco precursors,and their use as prodrugs
GB9707394.4 1997-04-10
GBGB9707394.4A GB9707394D0 (en) 1997-04-10 1997-04-10 Further cyclopropylindoles and their seco precursors, and their use as prodrugs
PCT/NZ1997/000117 WO1998011101A2 (en) 1996-09-12 1997-09-12 Condensed n-aclyindoles as antitumor agents

Publications (3)

Publication Number Publication Date
JP2000517292A JP2000517292A (ja) 2000-12-26
JP2000517292A5 true JP2000517292A5 (cg-RX-API-DMAC10.html) 2005-01-13
JP4155598B2 JP4155598B2 (ja) 2008-09-24

Family

ID=26310030

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53749297A Expired - Fee Related JP4155598B2 (ja) 1996-09-12 1997-09-12 抗癌剤としての縮合n−アシルインドール

Country Status (9)

Country Link
EP (1) EP0938474B1 (cg-RX-API-DMAC10.html)
JP (1) JP4155598B2 (cg-RX-API-DMAC10.html)
AT (1) ATE310725T1 (cg-RX-API-DMAC10.html)
AU (1) AU721037B2 (cg-RX-API-DMAC10.html)
CA (1) CA2265874C (cg-RX-API-DMAC10.html)
DE (1) DE69734722T2 (cg-RX-API-DMAC10.html)
ES (1) ES2253786T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ334344A (cg-RX-API-DMAC10.html)
WO (1) WO1998011101A2 (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE240334T1 (de) 1998-08-27 2003-05-15 Spirogen Ltd Pyrrolobenzodiazepine
GB9818730D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
GB9909612D0 (en) * 1999-04-26 1999-06-23 Cancer Res Campaign Tech N-protected amines and their use as prodrugs
US6909006B1 (en) * 1999-08-27 2005-06-21 Spirogen Limited Cyclopropylindole derivatives
BR0110414A (pt) * 2000-04-28 2003-02-11 Baxter Healthcare Sa Derivados de 2-acil indol e seu uso como agentes antitumores
DE50104114D1 (de) * 2000-05-02 2004-11-18 Tietze Lutz F Neue prodrugs von 6-hydroxy-2,3-dihydro-1h-indolen, 5-hydroxy-1,2-dihydro-3h-pyrrolo 3,2-e]indolen und 5-hydroxy-1,2-dihydro-3h-benzo e]indolen sowie von 6-hydroxy-1,2,3,4-tetrahydro-benzo f]chinolin-derivaten für eine selektive krebstherapie
DE60211905T2 (de) * 2001-02-22 2007-01-18 School Of Pharmacy, University Of London Benz-indol- und benzo-chinolin-derivate als prodrugs zur tumorbehandlung
AU2003228173A1 (en) * 2002-05-17 2003-12-02 Auckland Uniservices Limited Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-(ring fused indol-5-yl(amine-derived)) compounds and analogues thereof, and to products obtained therefrom
GB0226593D0 (en) 2002-11-14 2002-12-24 Consultants Ltd Compounds
ATE435649T1 (de) * 2003-05-02 2009-07-15 Elan Pharm Inc 4-brom-5-(2-chlor-benzoylamino)-1h-pyrazol-3- carbonsäure(phenyl)amid-derivate und verwandte verbindungen als bradykinin b1 receptor antagonisten zur behandlung von entzündlichen erkrankungen
ES2314418T3 (es) * 2003-05-02 2009-03-16 Elan Pharmaceuticals, Inc. Derivados de amidas del acido 4-bromo-5-(2-clorobenzoilamino)-1h-pirazol-3-carboxicilico y compuestos relacionados como antagonistas del receptor b1 de bradiquinina para el tratamiento de enfermedades inflamatorias.
GB0321295D0 (en) 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
NZ536107A (en) 2004-10-22 2007-06-29 Auckland Uniservices Ltd Nitrobenzindoles and their use in cancer therapy
WO2007059404A2 (en) * 2005-11-10 2007-05-24 Medarex, Inc. Duocarmycin derivatives as novel cytotoxic compounds and conjugates
CN101415679A (zh) * 2006-02-02 2009-04-22 辛塔佳有限公司 水溶性cc-1065类似物及其缀合物
WO2008039087A2 (en) * 2006-09-29 2008-04-03 Auckland Uniservices Limited Indoline derivatives and uses thereof
TWI412367B (zh) 2006-12-28 2013-10-21 Medarex Llc 化學鏈接劑與可裂解基質以及其之綴合物
WO2008103693A2 (en) 2007-02-21 2008-08-28 Medarex, Inc. Chemical linkers with single amino acids and conjugates thereof
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
AU2009320481C1 (en) 2008-11-03 2016-12-08 Syntarga B.V. Novel CC-1065 analogs and their conjugates
DE102009051438A1 (de) 2009-10-30 2011-05-05 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Fluoreszenzfarbstoffe
WO2011133039A2 (en) * 2010-04-21 2011-10-27 Syntarga B.V. Novel conjugates of cc-1065 analogs and bifunctional linkers
MY177390A (en) 2014-01-10 2020-09-14 Byondis Bv Method for purifying cys-linked antibody-drug conjugates
CN105899237B (zh) 2014-01-10 2019-09-03 斯索恩生物制药有限公司 用于治疗子宫内膜癌的倍癌霉素adc
SG10201911860VA (en) 2014-01-10 2020-02-27 Synthon Biopharmaceuticals Bv Duocarmycin adcs showing improved in vivo antitumor activity
CN108653288B (zh) * 2018-05-29 2020-05-05 福建医科大学孟超肝胆医院(福州市传染病医院) 一种乏氧响应聚合物纳米粒及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617304B2 (en) * 1986-12-19 1991-11-28 Pharmacia & Upjohn Company Novel cc-1065 analogs
JP2642165B2 (ja) * 1988-07-22 1997-08-20 協和醗酵工業株式会社 新規dc−89化合物およびその製造法
AU648313B2 (en) * 1990-04-25 1994-04-21 Pharmacia & Upjohn Company Novel CC-1065 analogs
GB9516943D0 (en) * 1995-08-18 1995-10-18 Cancer Soc Auckland Div Nz Inc Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
JPH11513391A (ja) * 1995-10-03 1999-11-16 ザ スクリップス リサーチ インスティテュート Cc−1065 及びズオカーマイシンのcbi 類縁体
US5985908A (en) * 1996-03-08 1999-11-16 The Scripps Research Institute MCBI analogs of CC-1065 and the duocarmycins

Similar Documents

Publication Publication Date Title
JP2002505592A5 (cg-RX-API-DMAC10.html)
JP2000506348A5 (cg-RX-API-DMAC10.html)
JP2000502280A5 (cg-RX-API-DMAC10.html)
JP2000504884A5 (cg-RX-API-DMAC10.html)
JP2000501018A5 (cg-RX-API-DMAC10.html)
JP2000500076A5 (cg-RX-API-DMAC10.html)
JP2001503295A5 (cg-RX-API-DMAC10.html)
JP2000501324A5 (cg-RX-API-DMAC10.html)
JP2001524152A5 (cg-RX-API-DMAC10.html)
JP2000500055A5 (cg-RX-API-DMAC10.html)
JP2001512478A5 (cg-RX-API-DMAC10.html)
JP2000500026A5 (cg-RX-API-DMAC10.html)
JP2000509515A5 (cg-RX-API-DMAC10.html)
JP2000502472A5 (cg-RX-API-DMAC10.html)
JP2000501825A5 (cg-RX-API-DMAC10.html)
JP2000500874A5 (cg-RX-API-DMAC10.html)
JP2000506091A5 (cg-RX-API-DMAC10.html)
JP2000502425A5 (cg-RX-API-DMAC10.html)
JP2000502485A5 (cg-RX-API-DMAC10.html)
JP2000502568A5 (cg-RX-API-DMAC10.html)
JP2000501774A5 (cg-RX-API-DMAC10.html)
JP2000500912A5 (cg-RX-API-DMAC10.html)
JP2001527517A5 (cg-RX-API-DMAC10.html)
JP2000502570A5 (cg-RX-API-DMAC10.html)
JP2000501876A5 (cg-RX-API-DMAC10.html)